High-dose intravenous methylprednisolone in myasthenia gravis.
about
Corticosteroids for myasthenia gravisClinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyLong-term corticosteroid treatment of myasthenia gravis.Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data.A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effectsPredictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.Early fast-acting treatment strategy against generalized myasthenia gravis.Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.Progress in the treatment of myasthenia gravisTreatment for refractory myasthenia gravis.Clinical evaluation and management of myasthenia gravis.Preoperative high-dose steroid has long-term beneficial effects for myasthenia gravis.Steroids and immunosuppressant drugs in myasthenia gravis.Glucocorticoids in myasthenia gravis - if, when, how, and how much?Myasthenia gravis: recent advances in immunopathology and therapy.The course of myasthenia gravis and therapies affecting outcome.Myasthenia gravis: immunological mechanisms and immunotherapy.Myasthenia gravis: lessons from the past 10 years.A treatment algorithm for autoimmune myasthenia gravis in childhood.High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia.A treatment algorithm for autoimmune myasthenia in adults.Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated.
P2860
Q24244116-5FB0F2BB-D4FD-4EBC-98F5-76038C10F1A9Q26765172-655A7B7E-A00E-480B-9655-FDBDAC26B165Q30462961-79C922E5-50A9-49E5-8DE2-E1CD7902D1B2Q30940140-2D655240-6ABE-4D91-A379-73766FE6AE40Q33628316-E09D03AF-0404-4754-806A-44A22A4EC396Q33651010-1661862A-1D27-4F53-A68F-F293A3390D49Q33834012-ED372D36-3CA9-4940-B2FA-021DD4812F76Q34043022-10C61528-83F8-4773-9351-B6B84D61143DQ34409088-C8FE8C4A-7779-4212-B6F7-FEE7D66774ABQ35625504-0A800481-521B-44EB-93B3-E1D7F371FC29Q35723879-4597B44B-71A3-40D6-993E-56AA69B82D0EQ37057779-6266AEB9-E66C-4F0A-B1E8-0C63BD106DF5Q37169005-8B4130F6-EC9C-4801-867F-A03840F0B281Q38234725-732A126A-C4AF-43BE-A850-7657BC92FDE4Q38969032-E2D2E585-FBAB-4750-AE02-DF97FDA933D0Q39683344-07665140-1A76-4416-8119-BB37D61F4F5AQ41270477-96A2449F-9685-49ED-BDF8-D0570351DE39Q46315266-56BC206D-742B-47DD-95F7-093B0F57E240Q47826083-A44A2EB5-61A3-478E-AB1F-082E57F1A16EQ48553519-130C05E1-5D0B-4CD3-A269-3B2A8BFA3785Q52239620-EC30D331-EB9A-47A1-8F44-4F0323181163Q52860272-29E90322-D114-4654-A7B2-E8090E6F6C5F
P2860
High-dose intravenous methylprednisolone in myasthenia gravis.
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
High-dose intravenous methylprednisolone in myasthenia gravis.
@ast
High-dose intravenous methylprednisolone in myasthenia gravis.
@en
High-dose intravenous methylprednisolone in myasthenia gravis.
@nl
type
label
High-dose intravenous methylprednisolone in myasthenia gravis.
@ast
High-dose intravenous methylprednisolone in myasthenia gravis.
@en
High-dose intravenous methylprednisolone in myasthenia gravis.
@nl
prefLabel
High-dose intravenous methylprednisolone in myasthenia gravis.
@ast
High-dose intravenous methylprednisolone in myasthenia gravis.
@en
High-dose intravenous methylprednisolone in myasthenia gravis.
@nl
P2093
P1433
P1476
High-dose intravenous methylprednisolone in myasthenia gravis.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1985.04060110031011
P577
1985-12-01T00:00:00Z